ReviewCPT: pharmacometrics & systems pharmacology2023

PBPK modeling of ivermectin-Considerations for the purpose of developing alternative routes to optimize its safety profile.

Karen Rowland Yeo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.